Abstract
Adoptive T cell transfer studies in mice and in cancer patients have shown substantial potential, but also major barriers, for successful therapeutic outcomes. A new strategy may overcome some of these barriers. T cells can now be engineered with 'autocostimulation' properties along with chimeric receptors specific for tumor antigens (pages 1440-1449).
Original language | English (US) |
---|---|
Pages (from-to) | 1411-1413 |
Number of pages | 3 |
Journal | Nature medicine |
Volume | 13 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2007 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology